Thyroid dysfunction in the era of precision medicine

  1. Juan Carlos Galofré Ferrater 1
  2. Juan José Díez Gómez 2
  3. David S. Cooper 3
  1. 1 Clínica Universitaria de Navarra
    info

    Clínica Universitaria de Navarra

    Pamplona, España

    ROR https://ror.org/03phm3r45

  2. 2 Hospital Ramón y Cajal
    info

    Hospital Ramón y Cajal

    Madrid, España

    ROR https://ror.org/050eq1942

  3. 3 John Hopkins University School of Medicine
Erakutsi afiliazioak +
Aldizkaria:
Endocrinología y nutrición: órgano de la Sociedad Española de Endocrinología y Nutrición

ISSN: 1575-0922

Argitalpen urtea: 2016

Alea: 63

Zenbakia: 7

Orrialdeak: 354-363

Mota: Artikulua

DOI: 10.1016/J.ENDONU.2016.04.009 DIALNET GOOGLE SCHOLAR

Beste argitalpen batzuk: Endocrinología y nutrición: órgano de la Sociedad Española de Endocrinología y Nutrición

Garapen Iraunkorreko Helburuak

Laburpena

The launching of the Precision Medicine Initiative by the President of the United States in January 2015 was an invitation for all healthcare professionals to review their practice. This call should stimulate thyroidologists working in different areas (from basic research or epidemiology to the frontline of the clinical arena or to those designing public health programs) to be aware of this new outlook. The aim of the initiative is to eradicate imprecision in estimating the probability of a correct diagnosis, to be as sure as possible of the most effective treatment, and to maximize the chances of a successful outcome. This paper summarizes some of the current challenges faced by endocrinologists in the field of thyroid dysfunction, and illustrates how precision medicine may improve diagnosis and therapy in the future.

Datuen iturria: Dialnet